SAN
DIEGO, Dec. 12, 2022 /PRNewswire/ -- NuVasive,
Inc. (NASDAQ: NUVA), the leader in spine technology innovation,
focused on transforming spine surgery with minimally disruptive,
procedurally integrated solutions, announced today that Chief
Executive Officer Chris Barry will
participate in the 41st Annual J.P. Morgan Healthcare
Conference in San Francisco
on Thursday, January 12, 2023 at 7:30
a.m. PT.
A live webcast of the presentation will be available online from
the Investor Relations page of the Company's website at
www.nuvasive.com. After the live webcast, a replay of the
presentation will remain available on the website for 30 days.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine
technology innovation, with a mission to transform surgery, advance
care, and change lives. The Company's less-invasive, procedurally
integrated surgical solutions are designed to deliver reproducible
and clinically proven outcomes. The Company's comprehensive
procedural portfolio includes surgical access instruments, spinal
implants, fixation systems, biologics, software for surgical
planning, navigation and imaging solutions, magnetically adjustable
implant systems for spine and orthopedics, and intraoperative
neuromonitoring technology and service offerings. With more
than $1 billion in net sales, NuVasive operates
in more than 50 countries serving surgeons, hospitals, and
patients. For more information, please
visit www.nuvasive.com.
Forward-Looking
Statements
NuVasive cautions you that statements included in this news
release that are not a description of historical facts are
forward-looking statements that involve risks, uncertainties,
assumptions and other factors which, if they do not materialize or
prove correct, could cause NuVasive's results to differ
materially from historical results or those expressed or implied by
such forward-looking statements. The potential risks and
uncertainties which contribute to the uncertain nature of these
statements include, among others, risks associated with acceptance
of the Company's surgical products and procedures by spine surgeons
and hospitals, development and acceptance of new products or
product enhancements, clinical and statistical verification of the
benefits achieved via the use of NuVasive's products, the
Company's ability to adequately manage inventory as it continues to
release new products, its ability to recruit and retain management
and key personnel, and the other risks and uncertainties described
in NuVasive's news releases and periodic filings with
the Securities and Exchange
Commission. NuVasive's public filings with
the Securities and Exchange Commission are available
at www.sec.gov. NuVasive assumes no obligation to
update any forward-looking statement to reflect events or
circumstances arising after the date on which it was made.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/nuvasive-to-participate-in-the-41st-annual-jp-morgan-healthcare-conference-301699928.html
SOURCE NuVasive, Inc.